About RAFT PHARMACEUTICALS LLC
RAFT Pharmaceuticals is a startup biopharmaceutical company developing novel therapies targeting lipid rafts in inflamed and activated cells, with a focus on chronic pain treatment. Their product, RFT1081, regulates cholesterol trafficking and has shown efficacy in preclinical models of neuropathic pain and migraine.
Development of novel therapeutic platforms targeting lipid raftsRegulation of cholesterol trafficking in plasma membranesNormalization of cholesterol-overloaded lipid raft microdomains in inflamed cellsPreclinical research in models of chemotherapy- and nerve injury-induced neuropathic painResearch in migraine treatment
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to RAFT PHARMACEUTICALS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.